According to ImmunoGen 's latest financial reports the company's total assets are NZ$1.35 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | NZ$0.54 B | -28.6% |
2021-12-31 | NZ$0.76 B | 56.42% |
2020-12-31 | NZ$0.49 B | 40.87% |
2019-12-31 | NZ$0.34 B | -20.67% |
2018-12-31 | NZ$0.44 B | 6.13% |
2017-12-31 | NZ$0.41 B | |
2016-06-30 | NZ$0.39 B | -13.84% |
2015-06-30 | NZ$0.45 B | 140.74% |
2014-06-30 | NZ$0.18 B | -31.66% |
2013-06-30 | NZ$0.27 B | 22.86% |
2012-06-30 | NZ$0.22 B | -14.48% |
2011-06-30 | NZ$0.26 B | 32.45% |
2010-06-30 | NZ$0.19 B | 26.28% |
2009-06-30 | NZ$0.15 B | 43.39% |
2008-06-30 | NZ$0.10 B | 4.72% |
2007-06-30 | NZ$0.10 B | -32.69% |
2006-06-30 | NZ$0.15 B | -3.48% |
2005-06-30 | NZ$0.16 B | -16.02% |
2004-06-30 | NZ$0.19 B | -5.43% |
2003-06-30 | NZ$0.20 B | -35.24% |
2002-06-30 | NZ$0.31 B | -20.03% |
2001-06-30 | NZ$0.39 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Seagen
SGEN | NZ$5.99 B | 342.07% | ๐บ๐ธ USA |
![]() Amgen AMGN | NZ$147.33 B | 10,770.56% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | NZ$147.37 B | 10,773.21% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | NZ$152.38 B | 11,142.78% | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | NZ$319.30 B | 23,458.05% | ๐บ๐ธ USA |
![]() Pfizer PFE | NZ$342.97 B | 25,204.43% | ๐บ๐ธ USA |
![]() Novartis NVS | NZ$164.77 B | 12,056.78% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | NZ$235.25 B | 17,256.99% | ๐ซ๐ท France |